Strange case of a particular jab maker

When India’s vaccine drive breaks down, big questions arise over Bharat Biotech’s premium price for Kovacsin’s private jobs. After all, public resources have contributed to its development

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *